When is dihydroergotamine (DHE) used in acute migraine management?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

When is dihydroergotamine (DHE) used in acute migraine management?

Dihydroergotamine is reserved for acute migraine management only after other acute therapies have failed or the attack is severe and refractory, requiring observation in a hospital or clinic because of its potent vasoconstrictive effects. It is not a first-line option for mild attacks you would treat at home, nor is it used as a daily preventive. In practice, it’s given in controlled settings (often with an antiemetic) and patients are monitored for vasospasm or ischemic complications, since ergot medicines can constrict blood vessels in the brain and other areas. It’s also not limited to pediatric patients.

Dihydroergotamine is reserved for acute migraine management only after other acute therapies have failed or the attack is severe and refractory, requiring observation in a hospital or clinic because of its potent vasoconstrictive effects. It is not a first-line option for mild attacks you would treat at home, nor is it used as a daily preventive. In practice, it’s given in controlled settings (often with an antiemetic) and patients are monitored for vasospasm or ischemic complications, since ergot medicines can constrict blood vessels in the brain and other areas. It’s also not limited to pediatric patients.

More practice questions